← Back to Clinical Trials
Recruiting NCT05778669

NCT05778669 KeySteps@JC Phase One Follow-up Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05778669
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Child Development
Study Type OBSERVATIONAL
Enrollment 1,486 participants
Start Date 2023-03-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 13 Years
Study Type OBSERVATIONAL
Interventions
Monitoring of medical, health and psychosocial conditions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,486 participants in total. It began in 2023-03-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This proposed study is a 5-year follow-up study of "KeySteps Phase One Study", which focused on bridging the gap between students from privileged and underprivileged families. This study will investigate the long-term effects of early childhood interventions provided during the kindergarten stage on primary school children and their families and track the health conditions and development of the Project children in their primary school stage. Cohort students of "KeySteps Phase One Study" will be invited to join this follow-up study. Data including children's health and psychosocial conditions, academic performance, and family demographics will be collected. In addition, subjects will receive on-site assessments on general health and learning. Medical and health-related events of subjects will be tracked through the existing health care system.

Eligibility Criteria

Inclusion Criteria: * Children and their families of the KS Phase One Study cohort in Academic Year 2018-19 * Children and their families are willing to join this follow-up study Exclusion Criteria: * Children and their families withdrew themselves from KS Phase One Study (KeySteps@JC - Early Child Intervention (KSJC) previously * Children cannot understand Chinese * Children's parents cannot understand Chinese * Children who are not studying primary schools in Hong Kong

Contact & Investigator

Central Contact

Patrick IP, MBBS, MPH

✉ patricip@hku.hk

📞 +852 2255 4090

Principal Investigator

Patrick IP, MBBS, MPH

PRINCIPAL INVESTIGATOR

The University of Hong Kong

Frequently Asked Questions

Who can join the NCT05778669 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 13 Years, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05778669 currently recruiting?

Yes, NCT05778669 is actively recruiting participants. Contact the research team at patricip@hku.hk for enrollment information.

Where is the NCT05778669 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT05778669 clinical trial?

NCT05778669 is sponsored by The University of Hong Kong. The principal investigator is Patrick IP, MBBS, MPH at The University of Hong Kong. The trial plans to enroll 1,486 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology